Skip to main content
Top
Published in: Neurological Sciences 6/2012

01-12-2012 | Original Article

Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia)

Authors: Ivana Z. Basta, Tatjana D. Pekmezović, Stojan Z. Perić, Darija B. Kisić-Tepavčević, Vidosava M. Rakočević-Stojanović, Zorica D. Stević, Dragana V. Lavrnić

Published in: Neurological Sciences | Issue 6/2012

Login to get access

Abstract

The aim of this study was to assess factors that might influence the health-related quality of life (HRQoL) in patients with myasthenia gravis (MG). A cross-sectional study was performed including 230 consecutive patients with MG. Severity of the disease was estimated according to the MGFA classification and QMG score. HRQoL was assessed by the SF-36 questionnaire. Depressive and anxiety symptoms were assessed using the Hamilton rating scales for depression and anxiety, respectively. Social support was measured by the Multidimensional Scale of Perceived Social Support (MSPSS), and acceptance of the disease by the Acceptance of Illness Scale. The significant demographic predictors of worse HRQoL in MG patients were older age (p = 0.025) and lower education (p = 0.012). Among clinical features, significant independent contributing factors of worse HRQoL were more severe form of the disease according to MGFA (p = 0.001) and higher QMG score (p = 0.001). Finally, psychosocial predictors of worse quality of life were lower MSPSS score (p = 0.001), poor acceptance of the disease (p = 0.001), as well as higher levels of anxiety and depression (p = 0.001). Our study revealed that the HRQoL in patients with MG is similarly reduced in its psychological and physical aspects. These results may have a practical implication pointing out that different aspects of psychosocial support should be added to the regular therapeutic protocols.
Literature
1.
go back to reference Meriggioli M, Sanders D (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475–490PubMedCrossRef Meriggioli M, Sanders D (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475–490PubMedCrossRef
2.
go back to reference Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R et al (2001) Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 22:363–369PubMedCrossRef Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R et al (2001) Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 22:363–369PubMedCrossRef
3.
go back to reference Mullins L, Carpentier M, Paul R, Sanders D (2008) Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 38:947–956PubMedCrossRef Mullins L, Carpentier M, Paul R, Sanders D (2008) Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 38:947–956PubMedCrossRef
4.
go back to reference Paul RH, Nash JM, Cohen R, Gilchist J, Goldstein J (2001) Quality of life and well-being of patients with myasthenia gravis. Muscle Nerve 24:512–516PubMedCrossRef Paul RH, Nash JM, Cohen R, Gilchist J, Goldstein J (2001) Quality of life and well-being of patients with myasthenia gravis. Muscle Nerve 24:512–516PubMedCrossRef
5.
go back to reference Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F et al (2010) The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 257:98–102PubMedCrossRef Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F et al (2010) The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 257:98–102PubMedCrossRef
6.
go back to reference Raggi A, Leonardi M, Mantegazza R, Casale S, Fioravanti G (2009) Social support and self-efficacy in patients with myasthenia gravis: a common pathway towards positive health outcomes. Neurol Sci 31:41–45PubMedCrossRef Raggi A, Leonardi M, Mantegazza R, Casale S, Fioravanti G (2009) Social support and self-efficacy in patients with myasthenia gravis: a common pathway towards positive health outcomes. Neurol Sci 31:41–45PubMedCrossRef
7.
go back to reference Raggi A, Leonardi M, Antozzi C, Confaloineri P, Maggi L, Cornelio F et al (2010) Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis. Neurol Sci 31:41–45PubMedCrossRef Raggi A, Leonardi M, Antozzi C, Confaloineri P, Maggi L, Cornelio F et al (2010) Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis. Neurol Sci 31:41–45PubMedCrossRef
8.
go back to reference Drulovic J, Pekmezovic T, Matejic B, Mesaros S, Manigoda M, Dujmovic I et al (2007) Quality of life in patients with multiple sclerosis in Serbia. Acta Neurol Scand 115:147–152PubMedCrossRef Drulovic J, Pekmezovic T, Matejic B, Mesaros S, Manigoda M, Dujmovic I et al (2007) Quality of life in patients with multiple sclerosis in Serbia. Acta Neurol Scand 115:147–152PubMedCrossRef
9.
go back to reference Peric S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V et al (2010) Health-related quality of life in patients with myotonic dystropy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg 110:71–77PubMed Peric S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V et al (2010) Health-related quality of life in patients with myotonic dystropy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg 110:71–77PubMed
10.
go back to reference Rostedt A, Padua L, Stalberg E (2006) Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire. Neurol Sci 27:91–96PubMedCrossRef Rostedt A, Padua L, Stalberg E (2006) Validation of the Swedish version of the disease-specific Myasthenia Gravis Questionnaire. Neurol Sci 27:91–96PubMedCrossRef
11.
go back to reference Rostedt A, Padua L, Stalberg EV (2006) Correlation between regional myasthenic weakness and mental aspects of quality of life. Eur J Neurol 13:191–193PubMedCrossRef Rostedt A, Padua L, Stalberg EV (2006) Correlation between regional myasthenic weakness and mental aspects of quality of life. Eur J Neurol 13:191–193PubMedCrossRef
12.
go back to reference Twork S, Wiesmeth S, Klewer J, Pohlau D, Kuglerg J (2010) Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 8:129PubMedCrossRef Twork S, Wiesmeth S, Klewer J, Pohlau D, Kuglerg J (2010) Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 8:129PubMedCrossRef
13.
go back to reference Winter Y, Schepelmann K, Spottke AE, Claus D, Grothe C, Schroder R et al (2010) Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 257:1473–1481PubMedCrossRef Winter Y, Schepelmann K, Spottke AE, Claus D, Grothe C, Schroder R et al (2010) Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 257:1473–1481PubMedCrossRef
14.
go back to reference Kulkantrakorn K, Sawanyawisuth K, Tiamkao S (2010) Factors correlating quality of life in patients with myasthenia gravis. Neurol Sci 31:571–573PubMedCrossRef Kulkantrakorn K, Sawanyawisuth K, Tiamkao S (2010) Factors correlating quality of life in patients with myasthenia gravis. Neurol Sci 31:571–573PubMedCrossRef
15.
go back to reference Chen YT, Chang Y, Chiu HC, Yeh JH (2011) Psychosocial aspects in myasthenic patients treated by plasmapheresis. J Neurol 258:1240–1246PubMedCrossRef Chen YT, Chang Y, Chiu HC, Yeh JH (2011) Psychosocial aspects in myasthenic patients treated by plasmapheresis. J Neurol 258:1240–1246PubMedCrossRef
16.
go back to reference Lavrnic D, Jerebinski M, Rakocevic-Stojanovic V, Stevic Z, Lavrnic S, Pavlovic S et al (1999) Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983–1992). Acta Neurol Scand 100:168–174PubMedCrossRef Lavrnic D, Jerebinski M, Rakocevic-Stojanovic V, Stevic Z, Lavrnic S, Pavlovic S et al (1999) Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983–1992). Acta Neurol Scand 100:168–174PubMedCrossRef
17.
go back to reference Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 76:1099–1102PubMedCrossRef Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry 76:1099–1102PubMedCrossRef
18.
go back to reference Basta I, Pekmezovic T, Padua L, Stojanovic V, Stevic Z, Nikolic A et al (2010) Validation of Serbian version of the disease-specific Myasthenia Gravis Questionnaire. Acta Neurol Scand 122:110–114PubMedCrossRef Basta I, Pekmezovic T, Padua L, Stojanovic V, Stevic Z, Nikolic A et al (2010) Validation of Serbian version of the disease-specific Myasthenia Gravis Questionnaire. Acta Neurol Scand 122:110–114PubMedCrossRef
19.
go back to reference Osserman KE, Genkins G (1971) Studies in myasthenia gravis: review of twenty-year experience in over 1200 patients. Mt Sinai J Med 38:497–537PubMed Osserman KE, Genkins G (1971) Studies in myasthenia gravis: review of twenty-year experience in over 1200 patients. Mt Sinai J Med 38:497–537PubMed
20.
go back to reference Stalberg E (1980) Clinical electrophysiology in myasthenia gravis. J Neurol Neurosurg Psychiatry 43:622–633PubMedCrossRef Stalberg E (1980) Clinical electrophysiology in myasthenia gravis. J Neurol Neurosurg Psychiatry 43:622–633PubMedCrossRef
21.
go back to reference Jeretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16–23CrossRef Jeretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16–23CrossRef
22.
go back to reference Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan W (1998) Reliability testing of the Quantitative Myasthenia Gravis Score. Ann N Y Acad Sci 841:769–772PubMedCrossRef Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan W (1998) Reliability testing of the Quantitative Myasthenia Gravis Score. Ann N Y Acad Sci 841:769–772PubMedCrossRef
23.
24.
25.
go back to reference Felton BJ, Revenson TA (1984) Coping with chronic illness: a study of illness controllability and influence of coping strategies on psychological adjustment. J Consult Clin Psychol 2:343–353 Felton BJ, Revenson TA (1984) Coping with chronic illness: a study of illness controllability and influence of coping strategies on psychological adjustment. J Consult Clin Psychol 2:343–353
26.
go back to reference Zimet GD, Powell SS, Farley GK et al (1990) Psychometric characteristics of the MSPSS. J Pers Assess 55:610–617PubMed Zimet GD, Powell SS, Farley GK et al (1990) Psychometric characteristics of the MSPSS. J Pers Assess 55:610–617PubMed
28.
go back to reference Ware JE, Sherbourne CD (1992) 36-Item Short-Form Health Survey (SF-36). Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef Ware JE, Sherbourne CD (1992) 36-Item Short-Form Health Survey (SF-36). Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef
29.
go back to reference Kulaksizoglu IB (2007) Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment. CNS Drugs 21:473–481PubMedCrossRef Kulaksizoglu IB (2007) Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment. CNS Drugs 21:473–481PubMedCrossRef
30.
go back to reference Pekmezovic T, Svetel M, Ivanovic N, Dragasevic N, Petrovic I, Kisic-Tepavcevic D et al (2009) Quality of life in patients with focal dystonia. Clin Neurol Neurosurg 111:161–164PubMedCrossRef Pekmezovic T, Svetel M, Ivanovic N, Dragasevic N, Petrovic I, Kisic-Tepavcevic D et al (2009) Quality of life in patients with focal dystonia. Clin Neurol Neurosurg 111:161–164PubMedCrossRef
31.
go back to reference Svetel M, Pekmezovic T, Tomic A, Kresojevic N, Potrebic A, Jesic R et al (2011) Quality of life in patients with treated and clinically stable Wilson’s disease. Mov Disord 26:1503–1508PubMedCrossRef Svetel M, Pekmezovic T, Tomic A, Kresojevic N, Potrebic A, Jesic R et al (2011) Quality of life in patients with treated and clinically stable Wilson’s disease. Mov Disord 26:1503–1508PubMedCrossRef
Metadata
Title
Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia)
Authors
Ivana Z. Basta
Tatjana D. Pekmezović
Stojan Z. Perić
Darija B. Kisić-Tepavčević
Vidosava M. Rakočević-Stojanović
Zorica D. Stević
Dragana V. Lavrnić
Publication date
01-12-2012
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 6/2012
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1170-2

Other articles of this Issue 6/2012

Neurological Sciences 6/2012 Go to the issue